3-44901672-G-A
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 1P and 2B. PP5BS1_SupportingBS2_Supporting
The NM_003241.4(TGM4):c.806G>A(p.Trp269*) variant causes a stop gained change. The variant allele was found at a frequency of 0.00785 in 1,614,152 control chromosomes in the GnomAD database, including 110 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.0079 ( 12 hom., cov: 33)
Exomes 𝑓: 0.0078 ( 98 hom. )
Consequence
TGM4
NM_003241.4 stop_gained
NM_003241.4 stop_gained
Scores
2
3
2
Clinical Significance
Conservation
PhyloP100: 5.43
Genes affected
TGM4 (HGNC:11780): (transglutaminase 4) Predicted to enable protein-glutamine gamma-glutamyltransferase activity. Predicted to be involved in peptide cross-linking. Predicted to act upstream of or within mating plug formation. Located in Golgi apparatus and collagen-containing extracellular matrix. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -1 ACMG points.
PP5
Variant 3-44901672-G-A is Pathogenic according to our data. Variant chr3-44901672-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 1184858.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.00785 (11475/1461816) while in subpopulation MID AF = 0.0359 (207/5768). AF 95% confidence interval is 0.0319. There are 98 homozygotes in GnomAdExome4. There are 6052 alleles in the male GnomAdExome4 subpopulation. Median coverage is 64. This position FAILED quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 12 AR geneVariant has number of homozygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TGM4 | NM_003241.4 | c.806G>A | p.Trp269* | stop_gained | Exon 7 of 14 | ENST00000296125.9 | NP_003232.2 | |
TGM4 | XM_011534042.3 | c.941G>A | p.Trp314* | stop_gained | Exon 8 of 15 | XP_011532344.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TGM4 | ENST00000296125.9 | c.806G>A | p.Trp269* | stop_gained | Exon 7 of 14 | 1 | NM_003241.4 | ENSP00000296125.4 | ||
TGM4 | ENST00000705784.1 | c.941G>A | p.Trp314* | stop_gained | Exon 8 of 15 | ENSP00000516167.1 | ||||
TGM4 | ENST00000422219.5 | n.*423G>A | downstream_gene_variant | 1 | ENSP00000403711.1 |
Frequencies
GnomAD3 genomes AF: 0.00790 AC: 1203AN: 152218Hom.: 12 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
1203
AN:
152218
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00902 AC: 2266AN: 251248 AF XY: 0.00990 show subpopulations
GnomAD2 exomes
AF:
AC:
2266
AN:
251248
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00785 AC: 11475AN: 1461816Hom.: 98 Cov.: 64 AF XY: 0.00832 AC XY: 6052AN XY: 727196 show subpopulations
GnomAD4 exome
AF:
AC:
11475
AN:
1461816
Hom.:
Cov.:
64
AF XY:
AC XY:
6052
AN XY:
727196
Gnomad4 AFR exome
AF:
AC:
55
AN:
33478
Gnomad4 AMR exome
AF:
AC:
324
AN:
44722
Gnomad4 ASJ exome
AF:
AC:
564
AN:
26134
Gnomad4 EAS exome
AF:
AC:
2
AN:
39700
Gnomad4 SAS exome
AF:
AC:
1280
AN:
86258
Gnomad4 FIN exome
AF:
AC:
608
AN:
53382
Gnomad4 NFE exome
AF:
AC:
7833
AN:
1111982
Gnomad4 Remaining exome
AF:
AC:
602
AN:
60392
Heterozygous variant carriers
0
714
1428
2142
2856
3570
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
280
560
840
1120
1400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00790 AC: 1203AN: 152336Hom.: 12 Cov.: 33 AF XY: 0.00839 AC XY: 625AN XY: 74490 show subpopulations
GnomAD4 genome
AF:
AC:
1203
AN:
152336
Hom.:
Cov.:
33
AF XY:
AC XY:
625
AN XY:
74490
Gnomad4 AFR
AF:
AC:
0.00132301
AN:
0.00132301
Gnomad4 AMR
AF:
AC:
0.0137872
AN:
0.0137872
Gnomad4 ASJ
AF:
AC:
0.0213379
AN:
0.0213379
Gnomad4 EAS
AF:
AC:
0.00019305
AN:
0.00019305
Gnomad4 SAS
AF:
AC:
0.010775
AN:
0.010775
Gnomad4 FIN
AF:
AC:
0.0119496
AN:
0.0119496
Gnomad4 NFE
AF:
AC:
0.00873067
AN:
0.00873067
Gnomad4 OTH
AF:
AC:
0.00850662
AN:
0.00850662
Heterozygous variant carriers
0
61
123
184
246
307
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
21
ALSPAC
AF:
AC:
20
ESP6500AA
AF:
AC:
5
ESP6500EA
AF:
AC:
86
ExAC
AF:
AC:
1013
Asia WGS
AF:
AC:
15
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Essential tremor Pathogenic:1
-
University of Washington Center for Mendelian Genomics, University of Washington
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:research
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
Vest4
GERP RS
Mutation Taster
=51/149
disease causing (fs/PTC)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: 26
Find out detailed SpliceAI scores and Pangolin per-transcript scores at